Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes*

By He Yan-Ling   Sabo Ron   Picard Franck   Wang Yibin   Herron Jerry   Ligueros-Saylan Monica   Dole William P.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1265-1272

Informa Healthcare

Access to resources Recommend Favorite

Role of vildagliptin in managing type 2 diabetes mellitus in the elderly

By Halimi S.   Raccah D.   Schweizer A.   Dejager S.  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1647-1656

Informa Healthcare

Access to resources Recommend Favorite

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimer's Disease

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 2, 2010-01 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

By Hanif W.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany

By Göke R.   Gruenberger J. B.   Bader G.   Dworak M.  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 785-789

Informa Healthcare

Access to resources Recommend Favorite